Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 378 Carcinoid Tumor 40 Gastro-enteropancreatic neuroendocrine tumor 36 Pancreatic Neoplasms 27 Carcinoma, Neuroendocrine 27 Neoplasms 25 Adenoma, Islet Cell 23 Pheochromocytoma 17 Paraganglioma 17 Neoplasm Metastasis 17 Stomach Neoplasms 15 Neuroblastoma 14 Gastrointestinal Neoplasms 14 Carcinoma, Hepatocellular 12 Thyroid Neoplasms 11 Prostatic Neoplasms 11 Breast Neoplasms 11 Sarcoma 10 Esophageal Neoplasms 10 Colorectal Neoplasms 10 Lung Neoplasms 9 Rectal Neoplasms 8 Gastrointestinal Stromal Tumors 8 Cholangiocarcinoma 8 Carcinoma, Medullary 8 Carcinoma 8 Brain Neoplasms 8 Anus Neoplasms 8 Liver Neoplasms 7 Colonic Neoplasms 7

Interventions

Serum Albumin 1 Data Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Intestinal Neuroendocrine Tumor × NET × Clear all

NCT06876532 2025-11-18

LUTIBI

Institut Claudius Regaud

Phase NA Recruiting

Intestinal Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡